Arvinas

Arvinas develops and commercializes small molecular therapeutics for the treatment of pro-inflammatory and autoimmune diseases.

Business Model:

Revenue: $112.2M

Employees: 201-500

Detailed Arvinas Information

Geographic Data

Arvinas headquarters map

Address: 395 Winchester Avenue

City: New Haven

State: CT

Zip: 06511

Country: US

Financial Info

Stage:

series c

Raised Last:

$55M

Raised Total:

$112M

Metrics

405,695Website Global Rank

130,037Website Monthly Traffic

Twitter Followers

Description

Arvinas develops and commercializes small molecular therapeutics for the treatment of pro-inflammatory and autoimmune diseases.

Contact Phone:
+12035351456

Contact Email:

Arvinas went public on 9/26/2018 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
9/26/2018

IPO Valuation:
$515M

Ticker Symbol:
ARVN

IPO Price:
$16/share

Amount Raised:
$120M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
2/2020 Oerth Bio Corporate Round 0
2/2020 Oerth Bio Corporate Round 0
Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research